A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers
about
How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipientsAntibody therapies for the prevention and treatment of viral infections.Novel approaches to CMV after HCT: report from the 27th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 22-25 April 2017.
P2860
A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A First-in-Human Study To Asse ...... alovirus in Healthy Volunteers
@en
type
label
A First-in-Human Study To Asse ...... alovirus in Healthy Volunteers
@en
prefLabel
A First-in-Human Study To Asse ...... alovirus in Healthy Volunteers
@en
P2093
P2860
P356
P1476
A First-in-Human Study To Asse ...... alovirus in Healthy Volunteers
@en
P2093
Adam Feire
Baldur Magnusson
Florencia Pereyra Segal
Janardhana Vemula
Juan C Rondon
Kiran Dole
Peter Pertel
Yinuo Pang
P2860
P304
P356
10.1128/AAC.02698-15
P407
P577
2016-02-29T00:00:00Z